DOJ FCPA Probe Focusing on Payments in Foreign Drug Trials

The Justice Department's so-called "pharma initiative" is investigating whether drug companies conducting foreign clinical trials have paid third-party investigators to finesse research data.

Get unlimited access to all Global Investigations Review content